Diabetes Blog

The FDA approved the inhaled insulin, Afrezza, last summer, and it will likely undergo a massive marketing campaign to providers and possibly to people with diabetes directly. Here is some important clinical trial information about the medicine and how it is indicated for use in patients.

Diabetes educator Debbie Berg discusses some strategies to make it easier to keep up with your regular regimen of medicine.

The FDA recently approved Lucentis for use of diabetic retinopathy. Pharmacist and certified diabetes educator Sam Grossman talks about the clinical trial results for the new drug and considerations of how people with the complication may want to consider talking to their provider about it.

Sanofi's recently approved insulin, Toujeo, is 300u/ml and offers clinicians and people with diabetes who have glycemic control issues another long-acting insulin. Sam Grossman discusses some of the studies' findings.

An FDA Panel recommends new safety information on DPP-4 inhibitors Onglyza and Nesina. Sam Grossman reviews this news and how it may affect marketing and prescribing of the medications.

How making an effort to improve upon sleeping and include walking as a regular activity can keep you healthier.